NCT03055832View on ClinicalTrials.gov

Comparison Between iLux™ and LipiFlow® in the Treatment of Meibomian Gland Dysfunction

NACompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

February 9, 2017

Primary Completion Date

July 20, 2017

Study Completion Date

July 20, 2017

Conditions
Meibomian Gland Dysfunction
Interventions
DEVICE

iLux 2020 System

Medical device that applies localized heat and pressure therapy to the eyelid in order to express melted meibum from obstructed glands

DEVICE

LipiFlow Pulsation System

Medical device that applies a combination of heat and pressure to the inner eyelid to remove gland obstructions and stagnant gland content

Trial Locations (7)

63017

TearFilm Investigative Site, Chesterfield

64111

TearFilm Investigative Site, Kansas City

80111

TearFilm Investigative Site, Greenwood Village

80112

TearFilm Investigative Site, Centennial

85016

TearFilm Investigative Site, Phoenix

92122

TearFilm Investigative Site, San Diego

95260

TearFilm Investigative Site, Scottsdale

All Listed Sponsors
lead

Tear Film Innovations, Inc.

INDUSTRY

NCT03055832 - Comparison Between iLux™ and LipiFlow® in the Treatment of Meibomian Gland Dysfunction | Biotech Hunter | Biotech Hunter